geroFarma SRL
The score of geroFarma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +1716 % Total assets +29 %
Accounts of the company itself (not consolidated).
The full file covers 4 financial years; a free account shows 2. →geroFarma's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 11 Jul 2026
- Year ended 31 Dec 2024filed on 11 Jul 2025
- Year ended 31 Dec 2023filed on 17 Jul 2024
- Year ended 31 Dec 2022filed on 24 Jul 2023
geroFarma's financial analysis
- Solvency22.9%sector median: 44.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of geroFarma
geroFarma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0774.941.908
- VAT number
- BE0774941908
- Peppol
- Registered · 0208:0774941908 · as of 27 Oct 2026
- Legal form
- SRL
- Incorporated
- 02 Oct 2021
- Registered office
- 8501 Kortrijk
- Latest accounts
- 2025 · filed on 11 Jul 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
geroFarma (SRL) has been based in Kortrijk since 2021, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 107,225 € and equity of 240,698 €; its revenue is not published. Its solvency stands at 22.9%, below the median of its sector (44.0%).
Companies similar to geroFarma
Companies in the same business, of comparable size and area, outside its group.
- Antoine Pharma Retail sale of pharmaceutical products Ixelles · balance sheet €1.46m
- Apkpharma Retail sale of pharmaceutical products Manage · balance sheet €1.05m
- Apotheek De Boeck Retail sale of pharmaceutical products Lierde · balance sheet €1.30m
- Duchi-Naert Retail sale of pharmaceutical products Harelbeke · balance sheet €1.52m
- VdC Invest Retail sale of pharmaceutical products Lierde · balance sheet 660,114 €
- Apone Retail sale of pharmaceutical products Hemiksem · balance sheet 653,679 €
- Pharmakes Retail sale of pharmaceutical products Ypres · balance sheet €1.74m
- Cardoen Pharma Retail sale of pharmaceutical products Wingene · balance sheet €1.79m
Frequently asked questions about geroFarma
What is the revenue of geroFarma?
geroFarma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of geroFarma?
In Belgium, the VAT number is the company number prefixed with BE: BE0774941908 for geroFarma, if the company is VAT-registered. Its company number (CBE) is 0774.941.908.
Where is the registered office of geroFarma?
According to the CBE register, the registered office of geroFarma is in 8501 Kortrijk.
What is the equity of geroFarma?
At the close of the 2025 financial year, the equity of geroFarma amounts to 240,698 €, a solvency of 22.9% of total assets.
Who manages geroFarma?
The register lists 1 active mandates at geroFarma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of geroFarma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →